Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- University of Arizona
Tucson, Arizona, United States
- University of California, Davis Health
Sacramento, California, United States
- Northwestern
Chicago, Illinois, United States
- University of Illinois Chicago
Chicago, Illinois, United States
- Northshore Hospital
Glenview, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Kansas
Kansas City, Kansas, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Baystate Health
Springfield, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- University of Missouri, Kansas City
Kansas City, Missouri, United States
- Lenox Hill/northern Westchester Hospital (northwell Health)
Mount Kisco, New York, United States
- Mount Sinai
New York, New York, United States
- University of North Carolina, School of Medicine
Chapel Hill, North Carolina, United States
- Duke
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Kaiser Permanente
Portland, Oregon, United States
- Temple University Hospital
Philadelphia, Pennsylvania, United States
- University of Pittsburg Medical Center
Pittsburgh, Pennsylvania, United States
- Baylor Scott & White (bsw) Health-North
Dallas, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
- University of Vermont
Burlington, Vermont, United States
- Providence Health and Services
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Feb 2020
- Primary completion
- 1 Mar 2026
- Completion
- 1 Mar 2026
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 1,032
- Registry id
- NCT04069312
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.